| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721614 | Diabetes & Metabolism | 2018 | 8 Pages |
Abstract
Carbamylation competes with glycation in vivo, especially under conditions of high glycation. Thus, the classic markers of glycaemic control should be interpreted with caution in diabetic patients with CKD because of this competitive effect.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
C. Nicolas, S. Jaisson, L. Gorisse, F.J. Tessier, C. Niquet-Léridon, P. Jacolot, C. Pietrement, P. Gillery,